Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254286 · ClinicalTrials.gov registry record · Phase 1
Food Effect Study in Healthy Volunteers
A Phase 1 study, sponsored by Biomea Fusion.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT07254286 is a Phase 1 study that has completed, run by Biomea Fusion. The registered enrollment target is 60 participants.
The verdict
NCT07254286, a Phase 1 study, has completed, sponsored by Biomea Fusion.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
A phase 1 open-label, randomized, crossover food effect and formulation assessment for icovamenib capsule in healthy volunteers.
Interventions
- DRUG Icovamenib
- DRUG Icovamenib HPMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-09-11 |
| Est. Completion | 2026-01-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07254286
The ClinicalTrials.gov registry entry for NCT07254286 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biomea Fusion, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Icovamenib is the first listed.
NCT07254286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07254286 about?
NCT07254286 is a clinical study titled "Food Effect Study in Healthy Volunteers". A phase 1 open-label, randomized, crossover food effect and formulation assessment for icovamenib capsule in healthy volunteers.
What is the current status of trial NCT07254286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2025-09-11. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT07254286?
The interventions under investigation include: Icovamenib (DRUG), Icovamenib HPMC (DRUG).
Who is sponsoring clinical trial NCT07254286?
This trial is sponsored by Biomea Fusion, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.